Aktis Oncology Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022
Period Ending	Jan '26 Jan 22, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Market Capitalization	1,176	-	-	-
Enterprise Value	942	-	-	-
Debt / Equity Ratio	0.06	0.05	0.13	0.01
Debt / FCF Ratio	-	1.01	-	-
Asset Turnover	0.02	0.01	-	-
Quick Ratio	9.18	15.85	15.74	24.38
Current Ratio	9.27	15.98	16.07	25.12
Return on Equity (ROE)	-26.50%	-25.18%	-24.42%	-
Return on Assets (ROA)	-14.80%	-14.51%	-16.68%	-
Return on Capital Employed (ROCE)	-28.90%	-16.90%	-30.00%	-14.90%
Buyback Yield / Dilution	-53.35%	-14.46%	-18.90%	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q